Please use this identifier to cite or link to this item:
|Title:||BRAF mutation is associated with the CpG island methylator phenotype in colorectal cancer from young patients||Authors:||Ang, P.W.
|Issue Date:||18-Jan-2009||Citation:||Ang, P.W., Li, W.Q., Soong, R., Iacopetta, B. (2009-01-18). BRAF mutation is associated with the CpG island methylator phenotype in colorectal cancer from young patients. Cancer Letters 273 (2) : 221-224. ScholarBank@NUS Repository. https://doi.org/10.1016/j.canlet.2008.08.001||Abstract:||This study investigated the relationship between BRAF mutation, the CpG island methylator phenotype (CIMP+) and APC methylation in colorectal cancer (CRC) from young patients. The V600E BRAF mutation was found in 7% of cases and was strongly associated with the tumour features of proximal site, advanced stage and poor histological grade. More than half (53%) the tumours with BRAF mutation were also CIMP+ as evaluated by a standard panel of markers, compared to only 4% of tumours with wildtype BRAF (P < 0.0001). In contrast to CIMP+, APC methylation was inversely correlated with BRAF mutation (P = 0.02). BRAF mutation and CIMP+ are therefore likely to be involved in an alternate, albeit rare, pathway to APC inactivation during the development of CRC in younger patients. © 2008 Elsevier Ireland Ltd. All rights reserved.||Source Title:||Cancer Letters||URI:||http://scholarbank.nus.edu.sg/handle/10635/115013||ISSN:||03043835||DOI:||10.1016/j.canlet.2008.08.001|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jan 23, 2020
WEB OF SCIENCETM
checked on Jan 15, 2020
checked on Jan 25, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.